Health Care & Life Sciences » Pharmaceuticals | Karolinska Development AB

Karolinska Development AB | Key People and Executives

Hans Lennart Rudolf Wigzell
Chairman
Y Y Tse
Director
Ewa Björling
Director
Karl Anders Olof Härfstrand
Director
Gunnar Magnus Modee Persson
Director
Khalid Islam
Director
Ping Tse
Vice Chairman
Vladimir Valeryevich Artamonov
Independent Director
Carl Johan Sundberg
Independent Director
Hans Lennart Rudolf Wigzell
Chairman
Viktor Drvota
Chief Executive & Investment Officer
Fredrik Järrsten
Chief Financial Officer
Y Y Tse
Director
Ewa Björling
Director
Karl Anders Olof Härfstrand
Director
Gunnar Magnus Modee Persson
Director
Khalid Islam
Director
Ping Tse
Vice Chairman
Elisabet Gimbringer
Controller
Vladimir Valeryevich Artamonov
Independent Director
Carl Johan Bertil Sundberg
Independent Director

About Karolinska Development AB

View Profile
Address
Tomtebodavägen 23A
Solna AB 171 65
Sweden
Employees -
Website http://www.karolinskadevelopment.com
Updated 07/08/2019
Karolinska Development AB engages in the investment in pharmaceutical business. It invests in companies that develop medical innovations, specialty care products and orphan drugs for patients suffering from life-threatening and serious debilitating conditions. Its funds are obtained from independent investors and shareholders by issuing and selling shares and interest-bearing instruments.